18
Participants
Start Date
January 31, 2012
Primary Completion Date
August 31, 2015
Study Completion Date
September 30, 2015
Mepolizumab
This is an anti IL-5 which is given once a month intravenously at the dose of 750 mg.
placebo
The placebo will consist of 100 mL normal saline solution (0.9%, 154 mmol/L sodium chloride).
Firestone Institute of Respiratory Health, St Joseph's Hospital, Hamilton
McMaster University
OTHER